Medmal (Medical malpractice)
-
The new chief executive has served on PI’s board since 2018, including as chair. -
The division mostly places higher up the tower, where many insurers have taken action to address SAM losses.
-
Sexual abuse and molestation exclusions are starting to hold in higher layers of hospital towers this year.
-
The change reflects the insurers’ recent deal with ProAssurance.
-
Despite tort reform, physicians’ insurers are struggling with the same loss inflation challenges as other liability peers.
-
While the Fed is more concerned with jobs, other macroeconomic concerns trouble the industry.
-
High H1 reserve releases of $7.4bn were driven by the largest of carriers.
-
Despite mild headline CPI, some insurance-related items are heading in a worrying direction.
-
An industry veteran of 34 years, the executive is known for placing US healthcare business in London.
-
Rising inflation could raise claims severity but also increase investment income.
-
PL coverage is being stripped out of admitted, packaged policies and increasingly purchased in the E&S market.
-
The FTC granted early termination of the waiting period, leaving the acquisition on track to finish in early 2026.
-
The vote paves the way for the finalization of the deal in the first half of 2026.
-
Tariffs could drive up property loss costs, but the impact on other items has been muted.
-
The impact of SAM claims is reverberating through the tower and the broader marketplace beyond hospitals.
-
A deep-dive analysis shows LitFin is not the boogeyman this industry paints it out to be.
-
The Insurance Insider US news team runs you through this week’s key agency M&A.
-
What insurers can learn from the history that led to this deal.
-
ProAssurance brands will be transitioned to The Doctors Company in "all/most markets" over time.
-
The Californian insurer is buying the medmal carrier for $25.00 per share, or a ~60% premium.
-
The executive is returning to Tysers after nearly four years at Price Forbes.
-
Profitability over growth continues to be the company’s “mantra”.
-
Frequency has rebounded, while severity has spiked beyond the pre-Covid-19 years.
-
Batch coverage is also coming into focus as insurers look for ways to reduce exposure to large losses.
